Fortress Biotech Inc (FBIO)
1.81
+0.05
(+2.84%)
USD |
NASDAQ |
Jul 05, 16:00
1.65
-0.16
(-8.84%)
After-Hours: 17:17
Fortress Biotech SG&A Expense (TTM): 86.72M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 86.72M |
December 31, 2023 | 94.12M |
September 30, 2023 | 99.71M |
June 30, 2023 | 108.12M |
March 31, 2023 | 112.73M |
December 31, 2022 | 113.66M |
September 30, 2022 | 113.16M |
June 30, 2022 | 105.24M |
March 31, 2022 | 95.57M |
December 31, 2021 | 86.84M |
September 30, 2021 | 74.95M |
June 30, 2021 | 68.12M |
March 31, 2021 | 63.19M |
December 31, 2020 | 61.17M |
September 30, 2020 | 59.69M |
June 30, 2020 | 58.64M |
March 31, 2020 | 57.63M |
December 31, 2019 | 55.59M |
September 30, 2019 | 55.84M |
June 30, 2019 | 53.69M |
March 31, 2019 | 53.30M |
December 31, 2018 | 53.37M |
September 30, 2018 | 36.31M |
June 30, 2018 | 45.98M |
March 31, 2018 | 49.56M |
Date | Value |
---|---|
December 31, 2017 | 50.90M |
September 30, 2017 | 63.12M |
June 30, 2017 | 50.14M |
March 31, 2017 | 42.13M |
December 31, 2016 | 35.18M |
September 30, 2016 | 32.64M |
June 30, 2016 | 30.90M |
March 31, 2016 | 26.07M |
December 31, 2015 | 21.63M |
September 30, 2015 | 17.62M |
June 30, 2015 | 13.22M |
March 31, 2015 | 11.81M |
December 31, 2014 | 10.41M |
September 30, 2014 | 10.19M |
June 30, 2014 | 9.596M |
March 31, 2014 | 9.709M |
December 31, 2013 | 10.10M |
September 30, 2013 | 9.807M |
June 30, 2013 | 9.718M |
March 31, 2013 | 9.159M |
December 31, 2012 | 8.675M |
September 30, 2012 | 7.784M |
June 30, 2012 | 7.508M |
March 31, 2012 | 7.162M |
December 31, 2011 | 5.755M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
55.59M
Minimum
Dec 2019
113.66M
Maximum
Dec 2022
82.67M
Average
86.72M
Median
Mar 2024
SG&A Expense (TTM) Benchmarks
Avenue Therapeutics Inc | 4.51M |
Journey Medical Corp | 39.04M |
Mustang Bio Inc | 8.792M |
Checkpoint Therapeutics Inc | 8.844M |
Viking Therapeutics Inc | 37.46M |